Developing phytoestrogens for breast cancer prevention. 2012

Mandy M Liu, and Ying Huang, and Jeffrey Wang
Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766, USA.

Breast cancer is one of the most common types of cancer in women, and is the second leading cause of cancer-related deaths in the United States. Chemoprevention using phytoestrogens (PEs) for breast cancer may be a valid strategy. PEs are phytochemicals with estrogen-like structures and can be classified into four types: isoflavones, lignans, stilbenes and coumestans. They are widely distributed in diet and herbs and have shown anti-cancer activity via mechanisms including estrogen receptor modulation, aromatase inhibition, and anti-angiogenesis. Genistein, daidzein and resveratrol are some of the most studied PE examples. Quality control in product manufacturing and clinical study design is a critical issue in developing them as clinically effective chemopreventive agents for breast cancer.

UI MeSH Term Description Entries
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016588 Anticarcinogenic Agents Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. Anti-Carcinogenic Agents,Anti-Carcinogenic Drugs,Anti-Carcinogenic Effect,Anti-Carcinogenic Effects,Anticarcinogenic Drugs,Anticarcinogenic Effect,Anticarcinogenic Effects,Anticarcinogens,Agents, Anti-Carcinogenic,Agents, Anticarcinogenic,Anti Carcinogenic Agents,Anti Carcinogenic Drugs,Anti Carcinogenic Effect,Anti Carcinogenic Effects,Drugs, Anti-Carcinogenic,Drugs, Anticarcinogenic,Effect, Anti-Carcinogenic,Effect, Anticarcinogenic,Effects, Anti-Carcinogenic,Effects, Anticarcinogenic
D048789 Phytoestrogens Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. Estrogen-Like Plant Extracts,Phyto-Estrogen,Phytoestrogen,Plant Estrogen,Plant Estrogens,Estrogen Like Plant Extracts,Estrogen, Plant,Estrogens, Plant,Extracts, Estrogen-Like Plant,Phyto Estrogen,Plant Extracts, Estrogen-Like
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug
D020847 Estrogen Receptor Modulators Substances that possess antiestrogenic actions but can also produce estrogenic effects as well. They act as complete or partial agonist or as antagonist. They can be either steroidal or nonsteroidal in structure. Antiestrogens,Antiestrogen,Estrogen Receptor Modulator,Modulator, Estrogen Receptor,Modulators, Estrogen Receptor,Receptor Modulator, Estrogen,Receptor Modulators, Estrogen

Related Publications

Mandy M Liu, and Ying Huang, and Jeffrey Wang
January 2000, Pharmazie in unserer Zeit,
Mandy M Liu, and Ying Huang, and Jeffrey Wang
January 2000, Menopause (New York, N.Y.),
Mandy M Liu, and Ying Huang, and Jeffrey Wang
April 2008, Environmental health perspectives,
Mandy M Liu, and Ying Huang, and Jeffrey Wang
October 2014, World journal of clinical oncology,
Mandy M Liu, and Ying Huang, and Jeffrey Wang
May 2003, American journal of obstetrics and gynecology,
Mandy M Liu, and Ying Huang, and Jeffrey Wang
November 2020, Biology,
Mandy M Liu, and Ying Huang, and Jeffrey Wang
February 2004, The American journal of clinical nutrition,
Mandy M Liu, and Ying Huang, and Jeffrey Wang
December 1998, Bailliere's clinical endocrinology and metabolism,
Mandy M Liu, and Ying Huang, and Jeffrey Wang
December 2002, The Journal of steroid biochemistry and molecular biology,
Mandy M Liu, and Ying Huang, and Jeffrey Wang
June 2001, Endocrine-related cancer,
Copied contents to your clipboard!